Infection
Antimicrobial impregnated catheters demonstrate efficacy and cost effectiveness
Published in Blood Weekly, July 1st, 2004
According to a study from the United States, "The antimicrobial impregnated central venous catheter (CVC) has been the most intensively studied technology for the prevention of CVC-related bloodstream infections (BSIs) over the past 30 years."
"Although more than a dozen randomized trials have shown significant benefit," wrote C.J. Cruich and colleagues, "authors of an analysis published in a recent issue of Clinical Infectious Diseases have raised questions about the efficacy of antimicrobial impregnated CVCs because of perceived defects in the experimental...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2004-07-01)
More Articles from Blood Weekly
- Stem Cells
Myoblasts converted to physiologically active neuronal phenotype - Stem-Cell Research
BM stem cells populate CNS into fully differentiated parenchymal microglia - Stem-Cell Transplantation
Lower doses of lymphocytes increase survival in myeloid leukemia - Acute Coronary Syndrome
Millennium, partner begin trial with INTEGRILIN (eptifibatide) Injection - Acute Lymphoblastic Leukemia
Family having hematopoietic cancers poses slight risk of offspring getting ALL - Acute myeloid leukemia
Fusion proteins overcome the hurdle of leukemia cell chemoresistance - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
